Selected Publications
As of May 15, 2003
Simon R, Freidlin B, Rubinstein L, Arbuck
S, Collins J, Christian M. Accelerated Titration Designs for Phase
I Clinical Trials in Oncology. Journal of the National Cancer
Institute 89, 1138-1147, 1997.
Becker KG, Simon RM, Bailey-Wilson J, Freidlin B,
Biddison, W, McFarland H, And Trent J. Clustering of non-MHC susceptibility
candidate loci in human autoimmune diseases. Proceedings of National
Academy of Science 17, 9979-9984, 1998.
Smith M, Freidlin B, Gloeckler Reis LA, and Simon
R. Trends in the Reported Incidence of Primary Malignant Brain Tumors
in Children in the United States. Journal of the National Cancer
Institute 90, 1269-1277, 1998.
Freidlin B, Gastwirth, JL. Unconditional Versions
of Several Tests Commonly Used in the Analysis of Contingency Tables.
Biometrics 55, 84-89. 1999.
Freidlin B, Podgor MJ, Gastwirth JL. Efficiency Robust
Tests for Survival and Ordered Categorical Data. Biometrics 55,
883-886, 1999.
Freidlin B, Korn EL and George SL. Data monitoring
committees and interim monitoring guidelines. Controlled Clinical
Trials 20, 395-407, 1999.
Freidlin B, and Gastwirth JL. Should the median test
be retired from the general use? American Statistician
54, 161-164, 2000.
Gastwirth JL, Freidlin B. On power and efficiency
robust linkage tests for affected sibs. Annals of Human Genetics
64, 443-453, 2000.
Freidlin B and Korn EL A testing procedure for survival
data with few responders. Statistics in Medicine 21, 65-78,
2002.
Freidlin B, Dancey J, Korn EL, Zee B, and Eisenhauer
E Multinomial phase II trial designs (letter). Journal of Clinical
Oncology 20, 599, 2002.
Zheng G, Freidlin B, Gastwirth JL. Robust TDT-type
candidate-gene association tests. Annals of Human Genetics.
(in press).